Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology*; D004351:Drug Resistance; D006160:Guanosine Triphosphate / Q000378:metabolism; D007941:Leukemia P388 / Q000188:drug therapy* / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D009368:Neoplasm Transplantation; D012254:Ribavirin / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D012263:Ribonucleosides / Q000494:pharmacology*; D013997:Time Factors
D000970:Antineoplastic Agents; D012263:Ribonucleosides; D012254:Ribavirin; D006160:Guanosine Triphosphate; C033706:tiazofurin